Cargando…
A Role for SMARCB1 in Synovial Sarcomagenesis Reveals That SS18–SSX Induces Canonical BAF Destruction
Reduced protein levels of SMARCB1 (also known as BAF47, INI1, SNF5) have long been observed in synovial sarcoma. Here, we show that combined Smarcb1 genetic loss with SS18–SSX expression in mice synergized to produce aggressive tumors with histomorphology, transcriptomes, and genome-wide BAF-family...
Autores principales: | Li, Jinxiu, Mulvihill, Timothy S., Li, Li, Barrott, Jared J., Nelson, Mary L., Wagner, Lena, Lock, Ian C., Pozner, Amir, Lambert, Sydney Lynn, Ozenberger, Benjamin B., Ward, Michael B., Grossmann, Allie H., Liu, Ting, Banito, Ana, Cairns, Bradley R., Jones, Kevin B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567602/ https://www.ncbi.nlm.nih.gov/pubmed/34078620 http://dx.doi.org/10.1158/2159-8290.CD-20-1219 |
Ejemplares similares
-
β-catenin stabilization enhances SS18-SSX2-driven synovial sarcomagenesis and blocks the mesenchymal to epithelial transition
por: Barrott, Jared J., et al.
Publicado: (2015) -
The impact of chromosomal translocation locus and fusion oncogene coding sequence in synovial sarcomagenesis
por: Jones, Kevin B., et al.
Publicado: (2016) -
SMARCB1 is required for widespread BAF complex-mediated activation of enhancers and bivalent promoters
por: Nakayama, Robert T., et al.
Publicado: (2017) -
SS18-SSX drives CREB activation in synovial sarcoma
por: Cyra, Magdalene, et al.
Publicado: (2022) -
Truncated SSX Protein Suppresses Synovial Sarcoma Cell Proliferation by Inhibiting the Localization of SS18-SSX Fusion Protein
por: Yoneda, Yasushi, et al.
Publicado: (2013)